Sarah M. Drawz
- Molecular Medicine top 0.1%
- Pharmacology top 1%
- Molecular Biology
- Epidemiology top 10%
- Pollution top 5%
- Co-authors
- Robert A. BonomoKrisztina M. Papp‐WallaceChristopher R. BethelFabio PratiEmilia CaselliFocco van den AkkerT. Andrew TatonMagdalena A. Taracila
- Topics
- Antibiotic Resistance in Bacteria (19 papers)Antibiotics Pharmacokinetics and Efficacy (11 papers)Escherichia coli research studies (4 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Sarah M. Drawz
23 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Medicine 1.6k
- Pharmacology 844
- Molecular Biology 618
- Epidemiology 456
- Pollution 315
Countries citing papers authored by Sarah M. Drawz
This map shows the geographic impact of Sarah M. Drawz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. Drawz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. Drawz more than expected).
Fields of papers citing papers by Sarah M. Drawz
This network shows the impact of papers produced by Sarah M. Drawz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. Drawz. The network helps show where Sarah M. Drawz may publish in the future.
Co-authorship network of co-authors of Sarah M. Drawz
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. Drawz. A scholar is included among the top collaborators of Sarah M. Drawz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. Drawz. Sarah M. Drawz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 55 | |
| 2 | 15 | |
| 3 | 10 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 14 | |
| 7 | 55 | |
| 8 | 16 | |
| 9 | 39 | |
| 10 | 24 | |
| 11 | 38 | |
| 12 | 16 | |
| 13 | 47 | |
| 14 | 16 | |
| 15 | 23 | |
| 16 | Three Decades of β-Lactamase Inhibitorsbreakdown → | 1280 |
| 17 | 59 | |
| 18 | 38 | |
| 19 | 25 | |
| 20 | 57 |
About Sarah M. Drawz
Sarah M. Drawz is a scholar working on Molecular Medicine, Endocrinology and Pharmacology, having authored 24 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Escherichia coli research studies (4 papers). The work is most often cited by research in Molecular Medicine (1.6k citations), Applied Microbiology and Biotechnology (237 citations) and Endocrinology (308 citations). Sarah M. Drawz has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Robert A. Bonomo, Krisztina M. Papp‐Wallace, Christopher R. Bethel, Fabio Prati, Emilia Caselli, Focco van den Akker, T. Andrew Taton, Magdalena A. Taracila, Youngjong Kang and Richard Watkins. Their work appears in journals such as Journal of the American Chemical Society, Biochemistry and Clinical Microbiology Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.